Search results
Shih-Ann Chen
Author
De Novo HF Versus ADCHF
Author(s):
Wilson Matthew Raffaello
,
Joshua Henrina
,
Ian Huang
,
et al
Added:
3 years ago
Article
New Horizons in Amyloidosis (NHA) 2024
Author(s):
Marianna Fontana
,
Julian Gillmore
,
Kevin Alexander
,
et al
Start date:
Feb 28, 2024
Broadcast
Dominik Linz
Job title: Cardiologist and Associate Professor
Author
Marcelo F Di Carli
Research Area(s) / Expertise:
Job title: Director, CV Imaging
Author
C Noel Bairey Merz
Research Area(s) / Expertise:
Job title: Cardiologist
Author
Author(s):
Tobias Koenig
,
Johann Bauersachs
,
Denise Hilfiker-Kleiner
Added:
3 years ago
Cardiovascular diseases (CVD) are a major cause of complications in pregnancies worldwide, and can be largely attributed to increased cardiovascular risk factors, such as obesity and hypertensive disorders.1 Today, up to 4% of all pregnancies are complicated by CVD, with increasing frequency.2 Cardiomyopathies – whether inherited or acquired – represent the leading cause of maternal morbidity and…
View more
Andrew Grace
Author
Author(s):
Veronika Zach
,
Felix Lucas Bähr
,
Frank Edelmann
Added:
4 years ago
Heart failure (HF) is a chronic, progressive disease with steadily increasing incidence rates and high morbidity and mortality that represents a major challenge in healthcare worldwide.1–3 The disease is characterised by chronic exacerbations, recurrent hospitalisations and poor prognosis.1,2 Survival rates in HF patients are lower than in patients suffering from some malignant diseases,…
View more
Author(s):
Yury Lopatin
Added:
3 years ago
In 2016, the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC)1 introduced heart failure (HF) with mid-range ejection fraction (HFmrEF) as a distinct phenotype. This distinction was expected to stimulate research on the underlying characteristics, pathophysiology and treatment of patients with HFmrEF. Indeed, in the following…
View more